Epigral Ltd

Epigral Ltd

893.70
INR
-27.50
(-2.99%)
62.73EPS
17.28P/E
46.77BMarket Cap
Nov 05Next Earn
Epigral Ltd
NSE:EPIGRAL
(National Stock Exchange of India)

Recent

price

893.70

P/E

ratio

17.28

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
143.71
170.89
146.85
198.77
372.98
522.13
455.79
595.28
578.44
607.85
Revenue per Share
37.42
44
26.95
24.27
60.84
85.03
47.14
84.68
76.95
62.73
Basic EPS, GAAP
24.41
-9.94
-49.24
7.8
-41.51
50.47
-0.19
58.21
9.59
- -
Free Cash Flow per Basic Share
- -
3.7
4.06
- -
- -
5.83
6.05
9.91
4.25
- -
Dividend per Share
124.51
67.83
89.66
113.89
174.72
257.3
301.83
441.46
514.92
- -
Book Value per Share
124.51
67.83
89.66
106.27
167.88
251.24
296.54
437.12
511.33
- -
Tangible Book Value per Share
42
42
42
42
42
42
42
42
43
43
Basic Weighted Avg Shares
5,971
7,101
6,102
8,259
15,497
21,694
18,938
25,144
24,955
26,260
Sales/Revenue/Turnover
33.51
36.49
24.82
22.74
27.35
26.73
18.89
23
16.02
15.74
Operating Margin (%)
553
541
443
735
859
1,090
1,236
1,326
1,683
1,697
Depreciation Expense
1,555
1,828
1,120
1,008
2,528
3,533
1,959
3,577
3,320
2,710
Net Income, GAAP
20.34
24.55
20.56
37.31
34.07
32.38
32.63
33.89
2.58
26.25
Effective Tax Rate (%)
26.04
25.74
18.36
12.21
16.31
16.28
10.34
14.23
13.3
10.32
Profit Margin (%)
343
771
-1,327
-2,073
-853
-2,282
-2,776
2,797
1,163
- -
Working Capital
9
3,653
4,220
3,435
5,598
4,360
4,921
4,523
3,362
- -
LT Debt
5,173
4,928
5,835
6,841
7,260
10,691
12,541
19,045
22,214
- -
Total Equity
- -
26.46
12.05
10.12
20.45
23.41
12.04
16.54
14.94
- -
Return on Invested Capital (%)
- -
25.06
11.84
10.27
20.03
23.13
11.89
16.56
14.27
- -
Return on Capital (%)
- -
45.75
34.23
23.85
42.16
39.36
16.86
22.65
16.09
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
2,358
- -
LT Borrowings
- -
3,337
- -
LT Finance Leases
- -
25
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
43
43
43
Market Capitalization
52,637
34,964
46,770

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
8,267
- -
Cash, Cash Equivalents & STI
- -
64
- -
Accounts Receivable, Net
- -
4,165
- -
Inventories
- -
3,486
- -
Total Current Liabilities
- -
7,104
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
2,358
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
27.84%
16.64%
Free Cash Flow
- -
-6,374.19%
-83.17%
Net Income, GAAP
- -
44.26%
-7.19%
Sales/Revenue/Turnover
- -
29.39%
-0.75%
Total Cash Common Dividend
- -
- -
-56.24%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
6,512
6,261
6,452
6,276
25,144
2026
6,065
5,874
5,971
7,362
24,955
2027
7,054
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
20.67
19.57
24.25
20.14
84.68
2026
37.18
11.87
9.07
18.76
76.95
2027
22.99
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
9.91
2026
- -
- -
- -
- -
4.25
2027
- -
- -
- -
- -
- -
Business
Epigral Limited manufactures and sells chlor-alkali products, chloromethanes, hydrogen peroxide, epichlorohydrin, chlorinated polyvinyl chloride compounds and resins, and chlorotoluenes in India and internationally; core offerings include caustic soda, caustic potash, chlorine, hydrogen, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, and epichlorohydrin derived from 100% renewable resources, serving industries such as pharmaceuticals, water treatment, epoxy resins, paper, textiles, and piping. The company, founded in 2007 and headquartered in Dahej, Gujarat, operates a backward- and forward-integrated manufacturing complex at its Dahej facility, backed by a 132 MW captive power plant, positioning it as India's fourth-largest caustic soda producer and largest CPVC resin producer. Epigral forays into the chlorotoluenes value chain with a project launch at its Dahej complex and in June 2025 agrees to acquire at least 26% of Pro-Zeal Green Power Ten Private Limited for Rs 21.38 crore to secure renewable energy supply. Formerly known as Meghmani Finechem Limited, Epigral maintains ISO 9001, 14001, 45001, and 50001 certifications, emphasizing sustainability through innovations like an 18.34 MW wind-solar hybrid plant and glycerol-based epichlorohydrin production.